Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Credible oncology updates at your fingertips.

Free. No ads. No bias.

Browse Clinical Trial Updates

All
Breast Cancer
CNS Malignancies
Conference Updates
Diagnostics
GI Cancers
GU Cancers
GYN Oncology
Hematologic Malignancies
Lung Cancer
Skin Cancer
Dr. Sandip Patel discusses the impact of adding chemotherapy in patients progressing on 1L osimertinib. (Video 1/3)

Dr. Sandip Patel discusses the impact of adding chemotherapy in patients progressing on 1L osimertinib. (Video 1/3)

OsiContinuation COMPEL

Sandip Patel, MD
Lung Cancer
Dr. Laura van ‘t Veer reviews ctDNA clearance at week 3 as an early indicator in breast cancer (Video 2/3)

Dr. Laura van ‘t Veer reviews ctDNA clearance at week 3 as an early indicator in breast cancer (Video 2/3)

ctDNA Week 3 Indicator

Breast Cancer
Dr. Joshua Richter discusses the MOA of CELMoDs and efficacy of MeziKd (Video 1/3)

Dr. Joshua Richter discusses the MOA of CELMoDs and efficacy of MeziKd (Video 1/3)

Mezigdomide MOA & MeziKd Efficacy

Hematologic Malignancies
Dr. Joe Mendez reviews vorasidenib for IDH mutant low-grade gliomas (Video 1/3)

Dr. Joe Mendez reviews vorasidenib for IDH mutant low-grade gliomas (Video 1/3)

INDIGO update

CNS Malignancies
Conference Updates
+1 more
Dr. Arnab Basu shares his thoughts on ctDNA-guided approaches and their impact to clinical practice today (Video 3/3)

Dr. Arnab Basu shares his thoughts on ctDNA-guided approaches and their impact to clinical practice today (Video 3/3)

ctDNA Outcomes

GU Cancers
Dr. Laura van ‘t Veer discusses baseline ctDNA as a predictive marker in neoadjuvant breast cancer (Video 1/3)

Dr. Laura van ‘t Veer discusses baseline ctDNA as a predictive marker in neoadjuvant breast cancer (Video 1/3)

ctDNA Baseline

Breast Cancer

Why subscribe?

  • Get one-minute, non-promotional, educational videos from distinguished thought leaders
  • Tailored to topics you select
    • Breast Cancer
    • Lung Cancer
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynecologic Cancers
    • Hemotologic Malignancies
    • Conference updates and more
  • No spam. No ads. No apps to download.
  • Always free and you can opt-out anytime if you feel this isn’t for you.

Fill out the form above to subscribe!

Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Intended for USA healthcare providers only.

If your institution is not listed, please input the Institution / Company name in the field below.

By clicking Subscribe, I agree that I have read and understand IDEOlogy Health’s Privacy Policy and Terms and Conditions and further agree to receive information from IDEOlogy Health and its companies

ideology-health
Inc. 5000

IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.